July 6, 2017July 6, 2017

Study Supports the Development of Envisia Genomic Classifier for IPF Diagnosis

Veracyte recently announced that results from a study supporting the development of the Envisia Genomic Classifier, a genomic test used to improve the diagnosis of idiopathic pulmonary fibrosis (IPF), have been ... Read more

May 12, 2017May 12, 2017

Genomic Classifiers Shown to Improve Diagnosis of Lung Cancer and IPF, Veracyte Says

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Multiple studies’ data support the use of Veracyte’s genomic classifiers to improve the diagnosis of lung cancer and idiopathic pulmonary fibrosis (IPF), the company reports. The data will be presented ... Read more